Glucovation’s CGM sensor detects glucose electrochemically via a proprietary non-enzymatic sensing technology. The sensor is painlessly inserted transcutaneously via a simplified “place and go” applicator and measures glucose in the interstitial fluid; the signal will be converted and then transmitted wirelessly to an existing commercial display device (phone, pad, or watch). Glucovation is focused on developing a system that requires no calibration yet is highly accurate for use in the medical and consumer markets. Glucovation is considering several strategic relationships with international manufacturing, development and distribution partners that are best of class. We will use these relationships to scale very quickly and deliver a solution that is unmatched in the market. With the nearly epidemic growth in diabetes, we are committed to delivering a solution that is easy to use, highest quality, best accuracy, and at a cost structure that will be very disruptive to the market.